GlaxoSmithKline announces investment in three UK sites

GlaxoSmithKline has brushed aside Brexit jitters and announced that it is pumping £275m into its three UK manufacturing sites, dubbing the UK an "attractive location".

The investment will go to sites at Barnard Castle, Durham, Montrose, Scotland, and Ware in Hertfordshire, and GSK said "new employment opportunities" are expected to be created as a result.